MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,815 | +76.7% | 58,274 | +160.0% | 0.00% | – |
| Q2 2023 | $102,871 | -86.5% | 22,412 | -85.4% | 0.00% | – |
| Q1 2023 | $761,582 | -93.5% | 153,855 | -92.8% | 0.00% | -100.0% |
| Q4 2022 | $11,652,978 | +52.6% | 2,134,245 | +81.7% | 0.00% | +50.0% |
| Q3 2022 | $7,636,000 | +20.2% | 1,174,674 | -12.6% | 0.00% | 0.0% |
| Q2 2022 | $6,355,000 | -39.3% | 1,343,542 | -10.2% | 0.00% | 0.0% |
| Q1 2022 | $10,462,000 | +5157.3% | 1,496,760 | +7560.4% | 0.00% | – |
| Q4 2021 | $199,000 | – | 19,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |